Yilong Wang

This study tests a new method of giving antibiotics for moderate-to-severe bacterial meningitis. Instead of only giving antibiotics through a vein, doctors will also inject them into the skull bone to help more medicine reach the brain. The trial will include 86 adults who have n…

This early-stage study tests whether a new drug, ALT001, is safe and shows any benefit for people with a rare brain disease called multiple system atrophy-cerebellar type (MSA-C). About 20 adults aged 30 to 75 with mild to moderate symptoms will receive the drug and be closely mo…

This early study tests if a drug called RK-4 can be safely injected through the skull into the brain for people with a severe stroke. The goal is to see if this method works and is safe for patients who cannot get standard treatments. Only 6 adults aged 18 to 80 with a first-time…

This early-phase study tests a new drug called ALT001 in 60 people with multiple system atrophy (MSA), a rare brain disease that affects movement and automatic body functions. The main goals are to check if the drug is safe and to see if it can help control symptoms. Participants…